View the file

Other files for this federal contract opportunity

Other files attached to 6515--761-23-2-014-0077 -Chelmsford CMOP CATH/SET INTERMIT, newest first.
File Type Posted
S02_Pricing Schedule_Q0117.xlsx XLSX spreadsheet
36C77023Q0117_1.docx DOCX document

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

VHAPG Part 813.106 Simplified Acquisition Procedures: Soliciting from a Single Source Attachment 1: Brand Name Justification for SAP under the SAT

DEPARTMENT OF VETERANS AFFAIRS

Justification for Brand Name Awards IAW FAR 13.106-1

For

Over Micro-Purchase Threshold but Not Exceeding the SAT ($2SOK)

Acquisition Plan Action ID: 36C770-23-AP-0211

1. Contracting Activity: Department of Veterans Affairs, Network Contracting Office 15, CMOP Division.

2237 # 761-23-2-014-0077, Chelmsford CMOP, Chelmsford, MA.

2. Brief Description of Supplies/ Services required and the intended use/Estimated Amount:

Item File Description MPN Quantity Unit of Packaging Number Number Measure Multiple

(IMF)

0001 6056 CATH SET, INTERMIT 14FR 96144 400 cs 4

H#96144 (XV066)

This is an individual brand name justification to support the procurement of the Med Surg item in the table above. The proposed procurement action will be a firm-fixed-price contract award.

3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used:

Product has been prescribed for patients by VA Physicians. Pharmacy employees do not have the training and/or authority to countermand physician orders. "Brand Specific" products are the same thing as "dispense as written" on a physician's prescription. No National Drug Code (NDC) substitutions are permitted. In the VA, Pharmacy Benefits Management (PBM) has determined that CMOP IDs in the National Drug File (NDF) will most always identify "brand specific" products in the VA PRINT NAME. This is not always inclusive where a particular NDC has been determined to be "formulation specific" by clinical evaluation performed by the PBM or in the case where only one product in the marketplace has been identified to contain the specific ingredients to match the product code.

Last Updated: 02/01/22 Page 1 of 2

File details come from the government source that posted it. Updated .